• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    10.61 Down 0.08(0.75%) May 27, 4:00PM EDT
    |After Hours : 10.61 0.00 (0.00%) May 27, 7:42PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 8,110   5,936   24,183   5,287  
    Cost of Revenue -   -   -   -  
    Gross Profit 8,110   5,936   24,183   5,287  
    Operating Expenses
    Research Development18,189  15,602  16,075  16,689  
    Selling General and Administrative5,372  4,860  4,378  4,718  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (15,451) (14,526) 3,730   (15,120)
    Income from Continuing Operations
    Total Other Income/Expenses Net(73)(485)734  1,097  
    Earnings Before Interest And Taxes(15,524)(18,261)9,314  (14,024)
    Interest Expense -   -   -   -  
    Income Before Tax(15,524)(18,261)9,314  (14,024)
    Income Tax Expense -  (309)(1,789) -  
    Minority Interest -   -   -  (86)
    Net Income From Continuing Ops(8,043)(21,201)10,444  (5,248)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (8,043) (17,952) 5,594   (6,248)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (8,043) (17,952) 5,594   (6,248)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.